Dr. Karim A. El-Kersh, MD

Dr. El-Kersh practices at Banner - University Medicine Orthopedic Clinic in Phoenix, Arizona.

Dr. El-Kersh's NPI, 1659681351, was assigned on October 14, 2010. Dr. El-Kersh holds Arizona license 69973.

Dr. El-Kersh's primary practice is Banner - University Medicine Orthopedic Clinic, at 755 E McDowell Rd, Phoenix, AZ 85006 in Maricopa County. The practice phone is (602) 839-2000.

Dr. El-Kersh's primary practice is Banner - University Medicine Orthopedic Clinic in Phoenix, Arizona. Dr. El-Kersh is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Medical Group (BMG). Dmand AI also links Dr. El-Kersh to 1 more therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Kersh practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. El-Kersh's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. El-Kersh is licensed in Arizona.

CMS data shows 84 Medicare services from Dr. El-Kersh across 2 procedure codes in 2024, for 79 Medicare patients. Medicare paid $6,423 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. El-Kersh in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El-Kersh's median patient age at 60, with 50% women.

In 2024, Dr. El-Kersh wrote 182 Medicare Part D claims for 29 patients. 32% of them were for generic drugs. CMS names the drug for 154 of them, across 7 drugs with 11 or more claims each, at $2,065,052 in total drug cost. In 2023, CMS named 211 claims across 7 drugs.

Dr. El-Kersh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. El-Kersh to 1 clinical trial. Conditions studied include Hypertension, Pulmonary and Hypertension. Open Payments lists research payments to Dr. El-Kersh that name 1 trial.

CMS Open Payments shows 285 general payments to Dr. El-Kersh from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 61% of the total. United Therapeutics Corporation paid the most, $125,965. It also lists 8 research payments totaling $5,127 from 2018 to 2023, naming 1 clinical trial.